2022 CIBERNED Webinar Series

Next Webinar

Thursday September 15, 2022 (15.30h)

Biofluid markers of synapse degeneration in neurodegenerative diseases

SpeakerOlivia Belbin (Senior investigator).

CIBERNED Group/InstitutionAlberto Lleó Sant Pau Research Institute and Hospital de la Santa Creu i Sant Pau - Program 1


CIBERNED Webinar Series 2022

On 1 January 2022, the Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), was merged by absorption into the Consorcio Centro de Investigación Biomédica en Red (CIBER), continuing and giving more scope to the scientific sessions, "CIBERNED Webinar Series". The aim of this tool is to share the latest scientific advances carried out in the CIBERNED thematic area, to make different members of the groups known through their active participation, and to stimulate interactions and collaborations between all CIBER members.

 

In this new stage, these are no longer internal seminars, but are now open to anyone who wishes to attend, in virtual format, in English and, of course, free of charge. The sessions lasts approximately 30 minutes, followed by a question and answer session and discussion for a total time of approximately 45-60 minutes. A few days prior to the webinar, the connection link to the Teams platform is published for anyone who wishes to access it.

The webinars scheduled so far are listed below. Those recorded sessions that have been authorised by the speakers will be published on the CIBERNED YouTube channel:

Calendar

DateSpeakerCIBERNED Group/InstitutionTitleVideo/Access
13-01-22
(15.30h)
Daniel Tornero (Senior researcher and lecturer) Jordi Alberch - Dept. of Biomedical Sciences, Institute of Neurosciences and Centre for the Production and Validation of Advanced Therapies (Creatio), University of Barcelona. August Pi I Sunyer Biomedical Research Institute (IDIBAPS). – Program 2 Functional Brain Reconstruction using stem cell-based therapy after brain damage Watch video
27-01-22
(15.30h)
Inés Moreno (Ramón y Cajal Investigator) Antonia Gutiérrez - Dept. of Cell Biology, Genetics and Physiology, Faculty of Science. University of Málaga – Program 1 Stem cell anti-inflammatory therapy to treat neurodegenerative diseases Watch video
10-02-22
(15.30h)
Javier Sáez (Senior researcher) Javier Sáez - Neurobiology and Neuropathology Unit, Institute of Neurosciences of Alicante, Miguel Hernández University -CSIC, Alicante – Program 1 Circulating ACE2 as a biomarker of SARS-CoV-2 infectivity, its relevance in COVID-19
24-02-22
(15.30h)
Montse Solé (Post-doctoral researcher) Joan X Comella - Cell Signalling and Apoptosis Group, Vall d'Hebron Research Institute (VHIR) and Biochemistry and Molecular Biology Dept. – Program 1 Novel roles of Fas apoptotic inhibitory molecule (FAIM) in neurodegeneration-associated pathology Watch video
10-03-22
(15.30h)
Ledia F Hernández José Obeso - HM Hospitals Comprehensive Neuroscience Centre (HM CINAC), Puerta del Sur Hospital and San Pablo CEU University. – Program 2 Optodyskinesias: evoking and inhibiting abnormal movements in a Parkinson disease model Watch video
24-03-22
(15.30h)
Alessandro Marrero (Pre-doctoral researcher) Abraham Acevedo - University Hospital of the Canary Islands and ITB-ULL, Tenerife – Program 3 Identification of a new functional interaction between TDP-43 and USP10 Watch video
07-04-22
(15.30h)
Ángel Martín (Neurologist, Hospital Universitario La Paz) María Jesús Bullido -Centro de Biología Molecular Severo Ochoa (CBMSO) Madrid (CSIC-UAM) – Program 1 Cholesterol in peripheral leucocytes of patients with Alzheimer´s Disease Watch video
21-04-22
(15.30h)
Alfredo Jesús Miñano Molina (Investigador Post-doctoral) José Rodríguez Álvarez - Institución: Instituto de Neurociencias (UAB) – Programa 1 AKAPs proteins as therapeutic target to early Alzheimer's disease

CANCELLED

05-05-22
(15.30h)
Marta Riba (Pre-doctoral researcher) Antonio Camins - Dept. of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona - Program 1 Wasteosomes (corpora amylacea): a physiological mechanism for the elimination of brain waste substances Watch video
19-05-22
(15.30h)
Santiago López-Begines (Post-doctoral researcher) Rafael Fernández-Chacón - Dept. of Medical Physiology and Biophysics, Faculty of Medicine, Hospital Universitario Virgen del Rocío/University of Seville; Institute of Biomedicine of Seville (IBIS) - Program 3 Mutations in DNAJC5 causing Kufs disease in humans induce lipofuscinosis in mice by a dominant-negative mechanism
02-06-22
(15.30h)
Isabel Lastres (Senior researcher) Javier Fernández-Ruiz - Dept. of Biochemistry and Molecular Biology, Faculty of Medicine, UAM; Instituto de Investigaciones Biomédicas Alberto Sols (UAM-CSIC); IdiPaz - Program 2 Unravel the molecular alterations associated to sporadic and SOD1-Amyotrophic Lateral Sclerosis to develop new multitargeted drugs as potential treatment
16-06-22
(15.30h)
Pascual Sánchez-Juan (Scientific Director, CIEN Foundation) CIEN Foundation, Carlos III Institute of Health (ISCIII) CIEN Foundation. Studies in the Alzheimer's continuum Watch video
30-06-22
(15.30h)
Mª Estrella Fernandez (Pre-doctoral researcher) Ignacio Torres - Department of Functional and Systems Neurobiology; Ramón y Cajal Institute of Neurobiology (CSIC) - Program 1. Insulin-like growth factor 1 mitigates post-traumatic stress by inhibiting AMP-Kinase in orexin neurons
07-07-22
(15.30h)
Fernando Bartolomé (Miguel Servet researcher) Eva Carro - Neurodegenerative Diseases Group, Research Institute of the Hospital Universitario 12 de Octubre, Madrid - Program 1. Sorl1 deficiency in Alzheimer’s disease: interaction with mitochondria Watch video

14-07-22

(15:30-17:30)

Luzma García (Coordinadora del Área de Transferencia de Tecnología de CIBER)

Juan Luque (Responsable Plataforma Desarrollo Tecnológico CIBER)

CIBER, Carlos III Institute of Health (ISCIII) La importancia de la transferencia tecnológica en la traslación de resultados en biomedicina: herramientas y procesos. Watch video
21-07-22
(15.30h)
Jaime Pignatelli (Researcher PhD) Ignacio Torres: Department of Functional and Systems Neurobiology; Ramón y Cajal Institute of Neurobiology (CSIC) - Program 1 Insulin-Like Growth Factor I couples metabolism with circadian activity through hypothalamic orexin neurons
15-09-22 Marta Cortés (Miguel Servet II Researcher) Ana Pérez-Castillo. Instituto de Investigación Sanitaria Fundación Jiménez Díaz and Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) - Program 2 Vascular component of Alzheimer's disease Watch video
29-09-22 Olivia Belbin (Senior Investigator) Alberto Lleó Sant Pau Research Institute and Hospital de la Santa Creu i Sant Pau - Program 1 Biofluid markers of synapse degeneration in neurodegenerative diseases Webinar access
06-10-22 Alberto Pascual (Senior Investigator) Javier Vitorica Institute of Biomedicine of Seville (IBiS). Virgen del Rocío University Hospital. CSIC.  University of Seville - Program 1 Non-productive angiogenesis in Alzheimer's disease
13-10-22 Albert Giralt (Ramón y Cajal Researcher) Jordi Alberch Department of Biomedicine, Faculty of Medicine and Health Sciences. Institute of Neurosciences. University of Barcelona - Program 2 Astrotherapeutics in neurodegenerative disorders and the role of BDNF
27-10-22 Julia Chocarro (Pre-doctoral Researcher) José Luis Lanciego Centre for Applied Medical Research. University of Navarra - Program 2 Blaming neuromelanin for Parkinson's disease: time-dependent tyrosinase overexpression drives endogenous synucleinopathy in non-human primates
10-11-22 Elisa Navarro (Assistant Professor) Javier Fernández-Ruiz Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universidad Complutense de Madrid - Programme 2 Role of LRRK2 in the innate immune system and its contribution to Parkinson's disease
24-11-22 Alfredo Jesús Miñano (Post-doctoral Researcher) José Rodríguez Institute of Neurosciences, Autonomous University of Barcelona - Program 1 AKAPs proteins as therapeutic target to early Alzheimer's disease
01-12-22 Julia Pose-Utrilla (Post-doctoral Researcher) Teresa Iglesias Instituto de Investigaciones Biomédicas de Madrid "Alberto Sols" (CSIC-UAM) - Program 2 Memory loss and other behavioral and synaptic alterations provoked by neuronal PKD1 deficits
15-12-22 Elena Sánchez-López (Post-doctoral Researcher) Antonio Camins Faculty of Pharmacy, University of Barcelona - Program 1 Biodegradable nanocarriers for the treatment of neurodegenerative diseases